![]() |
|
|
Vol. 297, Issue 3, 1193-1200, June 2001
Department of Anatomy and Cell Biology, Queen's University,
Kingston, Ontario, Canada (P.G.F., S.M.B.); and Department of Surgery,
University of Arizona, Tucson, Arizona (J.B.U.)
1,1-Dichloroethylene (DCE) elicits lung cytotoxicity and selectively
targets Clara cells of bronchioles. The toxic effects are ascribed to
CYP2E1-mediated formation of reactive intermediates including the DCE
epoxide. Here we tested the hypothesis that differential CYP2E1 levels
in the lungs of A/J, CD-1, and C57BL/6 mice lead to differences in the
extents of DCE bioactivation and lung damage. Our results showed that
lung CYP2E1 levels differed significantly in the three murine strains,
and followed the rank order A/J > CD-1 > C57BL/6. Covalent
binding of [14C]DCE to lung proteins in A/J mice was
significantly higher than in either CD-1 or C57BL/6 mice. HPLC analysis
of lung cytosol from DCE-treated mice showed that
2-S-glutathionyl acetate, a glutathione (GSH) conjugate
derived from the epoxide (conjugate [C]), was the major metabolite
formed. Levels of [C] detected in cytosol from A/J and CD-1 mice were
significantly higher than in C57BL/6 mice. Immunohistochemical staining
for [C] was pronounced in the lungs of A/J mice, was lower in CD-1
mice, and was lowest in C57BL/6 mice. Levels of GSH were similar in the
lungs of all untreated mice. However, significant reduction in GSH was
found in DCE-treated mice, with decreases comparable in all three
strains. Bronchiolar Clara cell damage was more severe in A/J and CD-1 mice than in C57BL/6 mice. These results showed differences in CYP2E1
levels in the lungs of A/J, CD-1, and C57BL/6 mice that correlated with
the extent to which the DCE epoxide is formed as well as with the
severity of lung cytotoxicity.
This article has been cited by other articles:
![]() |
E. J. Martin and P.-G. Forkert 1,1-Dichloroethylene-Induced Mitochondrial Damage Precedes Apoptotic Cell Death of Bronchiolar Epithelial Cells in Murine Lung J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 95 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Simmonds, C. A. Reilly, R. M. Baldwin, B. I. Ghanayem, D. L. Lanza, G. S. Yost, K. S. Collins, and P.-G. Forkert BIOACTIVATION OF 1,1-DICHLOROETHYLENE TO ITS EPOXIDE BY CYP2E1 AND CYP2F ENZYMES Drug Metab. Dispos., September 1, 2004; 32(9): 1032 - 1039. [Abstract] [Full Text] [PDF] |
||||